Quantum-Informed Holistic Hormonal Therapy (QHHT): A Unified Multidisciplinary Framework for Treating Female-Specific Cancers through Non-Equilibrium Hormonal and Cellular Reprogramming

The Quantum-Informed Holistic Hormonal Therapy (QHHT) framework presents a unified multidisciplinary approach to treat female-specific cancers (breast, ovarian, endometrial, cervical) by targeting the Dynamic Hormonal Field (DHF) as the driver of non-equilibrium tissue dynamics. QHHT integrates quantum chemistry, non-equilibrium thermodynamics, multiscale modeling, and a hybrid AI system combining physics-informed neural networks (PINNs), graph neural networks (GNNs), and reinforcement learning (RL) to deliver adaptive, personalized therapeutics. Cancer is modeled as a deviation from the minimum entropy production state, quantified through Onsager’s reciprocal relations, Fokker-Planck dynamics, fluctuation theorems, and density functional theory (DFT)-derived receptor-ligand interactions, utilizing time-dependent DFT (TD-DFT) and quantum mechanics/molecular mechanics (QM/MM) for precise analog design. Cross-scale coupling ensures energy conservation across quantum, molecular, cellular, and tissue levels. GNNs employ dynamic coarse-graining, with node counts scaling inversely with the spatial correlation length of entropy fluctuations, to model tumor heterogeneity. Real-time hormonal and immune data from wearable biosensors drive RL-optimized treatments, incorporating counter-regulatory hormones (e.g., cortisol, androgens) to prevent off-target entropy spikes. Organ-on-a-chip platforms measure entropy production components (chemical and transport) via nonequilibrium molecular dynamics (NEMD) and micro-calorimetry, validated against PINN predictions. SHAP-based explainable AI ensures clinical interpretability. QHHT correlates entropy minimization with suppression of oncogenic pathways (e.g., PI3K/AKT/mTOR) and immune activation, achieving scalability, reproducibility, and equity through open-source models and decentralized nanomanufacturing. This framework establishes a theoretically rigorous and practically implementable paradigm for precision oncology.